These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23637289)

  • 41. Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase.
    Fernández A; Pereira MJ; Suárez JM; Poza M; Treviño M; Villalón P; Sáez-Nieto JA; Regueiro BJ; Villanueva R; Bou G
    J Clin Microbiol; 2011 Mar; 49(3):822-8. PubMed ID: 21227991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IMP metallo-β-lactamase-producing clinical isolates of Enterobacter cloacae in the UK.
    Shet V; Gouliouris T; Brown NM; Turton JF; Zhang J; Woodford N
    J Antimicrob Chemother; 2011 Jun; 66(6):1408-9. PubMed ID: 21393151
    [No Abstract]   [Full Text] [Related]  

  • 43. Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant
    Gomez-Simmonds A; Annavajhala MK; Wang Z; Macesic N; Hu Y; Giddins MJ; O'Malley A; Toussaint NC; Whittier S; Torres VJ; Uhlemann AC
    mBio; 2018 May; 9(3):. PubMed ID: 29844109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France.
    Poirel L; Ros A; Carrër A; Fortineau N; Carricajo A; Berthelot P; Nordmann P
    J Antimicrob Chemother; 2011 May; 66(5):1181-2. PubMed ID: 21393189
    [No Abstract]   [Full Text] [Related]  

  • 45. Outbreak of CTX-M-15-producing Enterobacter cloacae associated with therapeutic beds and syphons in an intensive care unit.
    Bousquet A; van der Mee-Marquet N; Dubost C; Bigaillon C; Larréché S; Bugier S; Surcouf C; Mérat S; Blanchard H; Mérens A
    Am J Infect Control; 2017 Oct; 45(10):1160-1164. PubMed ID: 28571981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic Investigation and Successful Containment of an Intermittent Common Source Outbreak of OXA-48-Producing Enterobacter cloacae Related to Hospital Shower Drains.
    Nurjadi D; Scherrer M; Frank U; Mutters NT; Heininger A; Späth I; Eichel VM; Jabs J; Probst K; Müller-Tidow C; Brandt J; Heeg K; Boutin S
    Microbiol Spectr; 2021 Dec; 9(3):e0138021. PubMed ID: 34817232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
    Luo Y; Yang J; Ye L; Guo L; Zhao Q; Chen R; Chen Y; Han X; Zhao J; Tian S; Han L
    Microb Drug Resist; 2014 Aug; 20(4):264-9. PubMed ID: 24433026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital.
    Hays C; Benouda A; Poirel L; Elouennass M; Nordmann P
    Int J Antimicrob Agents; 2012 Jun; 39(6):545-7. PubMed ID: 22521525
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis.
    Shi ZY; Liu PY; Lau YJ; Lin YH; Hu BS
    J Clin Microbiol; 1996 Nov; 34(11):2784-90. PubMed ID: 8897183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular epidemiology of an outbreak of Enterobacter cloacae in the neonatal intensive care unit of a provincial hospital in Gauteng, South Africa.
    van Nierop WH; Duse AG; Stewart RG; Bilgeri YR; Koornhof HJ
    J Clin Microbiol; 1998 Oct; 36(10):3085-7. PubMed ID: 9738077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan.
    Harada S; Aoki K; Ohkushi D; Okamoto K; Takehana K; Akatsuchi T; Ida K; Shoji D; Ishii Y; Doi Y; Moriya K; Hayama B
    BMC Infect Dis; 2021 Mar; 21(1):289. PubMed ID: 33752612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization and antimicrobial susceptibility of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico.
    Garza-González E; Mendoza Ibarra SI; Llaca-Díaz JM; Gonzalez GM
    J Med Microbiol; 2011 Jan; 60(Pt 1):84-90. PubMed ID: 20930052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
    Hayakawa K; Miyoshi-Akiyama T; Kirikae T; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Kubota S; Takeshita N; Kutsuna S; Tojo M; Ohmagari N
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3441-50. PubMed ID: 24709261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance.
    Mezzatesta ML; Gona F; Stefani S
    Future Microbiol; 2012 Jul; 7(7):887-902. PubMed ID: 22827309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria.
    Heller I; Grif K; Orth D
    J Med Microbiol; 2012 Apr; 61(Pt 4):567-571. PubMed ID: 22194339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit.
    Grattard F; Pozzetto B; Berthelot P; Rayet I; Ros A; Lauras B; Gaudin OG
    J Clin Microbiol; 1994 Mar; 32(3):596-602. PubMed ID: 8195364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
    Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
    Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae.
    Gacar GG; Midilli K; Kolayli F; Ergen K; Gundes S; Hosoglu S; Karadenizli A; Vahaboglu H
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4400-3. PubMed ID: 16189133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal distribution of multidrug-resistant Enterobacter cloacae.
    Girlich D; Poirel L; Nordmann P
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):264-8. PubMed ID: 25680336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.